Chris

Brilliant, although you would be disappointed if an antiviral designed to fight covid didn’t perform better than one designed to fight a different respiratory illness that isn’t even caused by the same class of virus. It’s remarkable that Molnupiravir works at all really, but just as well because this one is still going to be a good few months away from widespread availability.

Biomedical science is where it’s all happening right now though isn’t it. So many remarkable achievements in such a short time.